A Radiomics Nomogram for Preoperative Prediction of Clinical Occult Lymph Node Metastasis in cT1-2N0M0 Solid Lung Adenocarcinoma

References

• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30. doi:10.3322/caac.2116623335087
   PubMed Web of Science ®Google Scholar
• Aberle DR, Adams AM; The National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395–409.21714641
   PubMed Web of Science ®Google Scholar
• Howington JA, Blum MG, Chang AC, Balekian AA, Murthy SC. Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines. Chest. 2013;143(5):e278S–e313S.23649443
   PubMed Web of Science ®Google Scholar
• Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010;303(11):1070–1076. doi:10.1001/jama.2010.26120233825
   PubMed Web of Science ®Google Scholar
• Bilal H, Mahmood S, Rajashanker B, Shah R. Is radiofrequency ablation more effective than stereotactic ablative radiotherapy in patients with early stage medically inoperable non-small cell lung cancer? Interact Cardiovasc Thorac Surg. 2012;15(2):258–265. doi:10.1093/icvts/ivs17922581864
   PubMed Web of Science ®Google Scholar
• Shirvani SM, Jiang J, Chang JY, et al. Comparative effectiveness of five treatment strategies for early-stage non-small cell lung cancer in the elderly. Int J Radiat Oncol Biol Phys. 2012;84(5):1060–1070. doi:10.1016/j.ijrobp.2012.07.235422975611
   PubMed Web of Science ®Google Scholar
• Judy GD, Kaidar-Person O, Deal A, et al. The persistent problem of local/regional failure after surgical intervention for early-stage lung cancer. Ann Thorac Surg. 2018;106(2):382–389. doi:10.1016/j.athoracsur.2018.03.06229723532
   PubMed Web of Science ®Google Scholar
• van den Berg LL, Klinkenberg TJ, Groen HJ, Widder J. Patterns of recurrence and survival after surgery or stereotactic radiotherapy for early stage NSCLC. J Thorac Oncol. 2015;10(5):826–831. doi:10.1097/JTO.000000000000048325629639
   PubMed Web of Science ®Google Scholar
• Silvestri GA, Gould MK, Margolis ML, et al. Noninvasive staging of non-small cell lung cancer. Chest. 2007;132(3):178S–201S. doi:10.1378/chest.07-136017873168
   PubMed Web of Science ®Google Scholar
• Andersen MB, Harders SW, Ganeshan B, Thygesen J, Torp Madsen HH, Rasmussen F. CT texture analysis can help differentiate between malignant and benign lymph nodes in the mediastinum in patients suspected for lung cancer. Acta Radiol. 2016;57(6):669–676. doi:10.1177/028418511559880826271125
   PubMed Web of Science ®Google Scholar
• Rogasch JM, Apostolova I, Steffen IG, et al. Standardized visual reading of F18-FDG-PET in patients with non-small cell lung cancer scheduled for preoperative thoracic lymph node staging. Eur J Radiol. 2016;85(8):1345–1350. doi:10.1016/j.ejrad.2016.05.00427423672
   PubMed Web of Science ®Google Scholar
• Feng M, Yang X, Ma Q, He Y. Retrospective analysis for the false positive diagnosis of PET-CT scan in lung cancer patients. Medicine. 2017;96(42):e7415. doi:10.1097/MD.000000000000741529049175
   PubMed Web of Science ®Google Scholar
• Huang Y, Liu Z, He L, et al. Radiomics signature: a potential biomarker for the prediction of disease-free survival in early-stage (I or II) non-small cell lung cancer. Radiology. 2016;281(3):947–957. doi:10.1148/radiol.201615223427347764
   PubMed Web of Science ®Google Scholar
• Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2016;278(2):563–577. doi:10.1148/radiol.201515116926579733
   PubMed Web of Science ®Google Scholar
• Lee G, Lee HY, Park H, et al. Radiomics and its emerging role in lung cancer research, imaging biomarkers and clinical management: state of the art. Eur J Radiol. 2017;86:297–307. doi:10.1016/j.ejrad.2016.09.00527638103
   PubMed Web of Science ®Google Scholar
• Verma V, Simone CB 2nd, Krishnan S, Lin SH, Yang J, Hahn SM. The rise of radiomics and implications for oncologic management. J Natl Cancer Inst. 2017;109(7). doi:10.1093/jnci/djx055
   PubMedGoogle Scholar
• Yang X, Pan X, Liu H, et al. A new approach to predict lymph node metastasis in solid lung adenocarcinoma: a radiomics nomogram. J Thorac Dis. 2018;10(Suppl 7):S807–S819. doi:10.21037/jtd.2018.03.12629780627
   PubMed Web of Science ®Google Scholar
• Zhong Y, Yuan M, Zhang T, Zhang YD, Li H, Yu TF. Radiomics approach to prediction of occult mediastinal lymph node metastasis of lung adenocarcinoma. Am J Roentgenol. 2018;211(1):109–113. doi:10.2214/AJR.17.1907429667885
   PubMed Web of Science ®Google Scholar
• Matsuguma H, Yokoi K, Anraku M, et al. Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung: a predictor of lymph node metastasis. J Thorac Cardiovasc Surg. 2002;124(2):278–284. doi:10.1067/mtc.2002.12229812167787
   PubMed Web of Science ®Google Scholar
• van Griethuysen JJM, Fedorov A, Parmar C, et al. Computational radiomics system to decode the radiographic phenotype. Cancer Res. 2017;77(21):e104–e107. doi:10.1158/0008-5472.CAN-17-033929092951
   PubMed Web of Science ®Google Scholar
• Collins GS, Reitsma JB, Altman DG, Moons KGM. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ. 2015;102(3):148–158.
   Google Scholar
• Kramer AA, Zimmerman JE. Assessing the calibration of mortality benchmarks in critical care: the Hosmer-Lemeshow test revisited. Crit Care Med. 2007;35(9):2052–2056. doi:10.1097/01.CCM.0000275267.64078.B017568333
   PubMed Web of Science ®Google Scholar
• Giaj-Levra N, Borghetti P, Bruni A, et al. Current radiotherapy techniques in NSCLC: challenges and potential solutions. Expert Rev Anticancer Ther. 2020;20(5):387–402. doi:10.1080/14737140.2020.176009432321330
   PubMed Web of Science ®Google Scholar
• Figlia V, Mazzola R, Cuccia F, et al. Hypo-fractionated stereotactic radiation therapy for lung malignancies by means of helical tomotherapy: report of feasibility by a single-center experience. Radiol Med. 2018;123(6):406–414. doi:10.1007/s11547-018-0858-729455424
   PubMed Web of Science ®Google Scholar
• Cuccia F, Mortellaro G, Mazzola R, et al. Prognostic value of two geriatric screening tools in a cohort of older patients with early stage non-small cell lung cancer treated with hypofractionated stereotactic radiotherapy. J Geriatr Oncol. 2020;11(3):475–481. doi:10.1016/j.jgo.2019.05.00231122872
   PubMed Web of Science ®Google Scholar
• Gu Y, She Y, Xie D, et al. A texture analysis-based prediction model for lymph node metastasis in stage I a lung adenocarcinoma. Ann Thorac Surg. 2018;106(1):214–220. doi:10.1016/j.athoracsur.2018.02.02629550204
   PubMed Web of Science ®Google Scholar
• Li L, Ren S, Zhang Y, et al. Risk factors for predicting the occult nodal metastasis in T1-2N0M0 NSCLC patients staged by PET/CT: potential value in the clinic. Lung Cancer. 2013;81(2):213–217. doi:10.1016/j.lungcan.2013.04.01223664030
   PubMed Web of Science ®Google Scholar
• Park HK, Jeon K, Koh WJ, et al. Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT. Respirology. 2010;15(8):1179–1184. doi:10.1111/j.1440-1843.2010.01793.x20573058
   PubMed Web of Science ®Google Scholar
• Kim DH, Song BI, Hong CM, et al. Metabolic parameters using 18F-FDG PET/CT correlate with occult lymph node metastasis in squamous cell lung carcinoma. Eur J Nucl Med Mol Imaging. 2014;41(11):2051–2057. doi:10.1007/s00259-014-2831-624990401
   PubMed Web of Science ®Google Scholar
• Zhang Y, Sun Y, Xiang J, Zhang Y, Hu H, Chen H. A prediction model for N2 disease in T1 non–small cell lung cancer. J Thorac Cardiovasc Surg. 2012;144(6):1360–1364. doi:10.1016/j.jtcvs.2012.06.05022819364
   PubMed Web of Science ®Google Scholar
• Shafazand S, Gould MK. A clinical prediction rule to estimate the probability of mediastinal metastasis in patients with non-small cell lung cancer. J Thorac Oncol. 2006;1(9):953–959. doi:10.1016/S1556-0864(15)31627-017409978
   PubMed Web of Science ®Google Scholar
• Chen K, Yang F, Jiang G, Li J, Wang J. Development and validation of a clinical prediction model for n2 lymph node metastasis in non-small cell lung cancer. Ann Thorac Surg. 2013;96(5):1761–1768. doi:10.1016/j.athoracsur.2013.06.03823998401
   PubMed Web of Science ®Google Scholar
• Feng Q, Yu M, Kiviat NB. Molecular biomarkers for cancer detection in blood and bodily fluids. Crit Rev Clin Lab Sci. 2006;43(5–6):497–560.17050080
   PubMed Web of Science ®Google Scholar
• Villalobos P, Wistuba II. Lung cancer biomarkers. Hematol Oncol Clin North Am. 2017;31(1):13–29. doi:10.1016/j.hoc.2016.08.00627912828
   PubMed Web of Science ®Google Scholar
• Moon Y, Choi SY, Park JK, Lee KY. Risk factors for occult lymph node metastasis in peripheral non-small cell lung cancer with invasive component size 3 cm or less. World J Surg. 2020;44(5):1658–1665. doi:10.1007/s00268-019-05365-531912252
   PubMed Web of Science ®Google Scholar
• Wang X, Zhao X, Li Q, et al. Can peritumoral radiomics increase the efficiency of the prediction for lymph node metastasis in clinical stage T1 lung adenocarcinoma on CT? Eur Radiol. 2019;29(11):6049–6058. doi:10.1007/s00330-019-06084-030887209
   PubMed Web of Science ®Google Scholar
• Lambin P, Rios-Velazquez E, Leijenaar R, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012;48(4):441–446. doi:10.1016/j.ejca.2011.11.03622257792
   PubMed Web of Science ®Google Scholar
• Aerts HJ, Velazquez ER, Leijenaar RT, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014;5(1):4006. doi:10.1038/ncomms500624892406
   PubMed Web of Science ®Google Scholar
• Liu Y, Kim J, Balagurunathan Y, et al. Prediction of pathological nodal involvement by CT-based Radiomic features of the primary tumor in patients with clinically node-negative peripheral lung adenocarcinomas. Med Phys. 2018;45(6):2518–2526. doi:10.1002/mp.1290129624702
   PubMed Web of Science ®Google Scholar
• Rusch VW, Hawes D, Decker PA, et al. Occult metastases in lymph nodes predict survival in resectable non-small-cell lung cancer: report of the ACOSOG Z0040 trial. J Clin Oncol. 2011;29(32):4313–4319. doi:10.1200/JCO.2011.35.250021990404
   PubMed Web of Science ®Google Scholar
• Seto K, Kuroda H, Yoshida T, et al. Higher frequency of occult lymph node metastasis in clinical N0 pulmonary adenocarcinoma with ALK rearrangement. Cancer Manag Res. 2018;10:2117–2124. doi:10.2147/CMAR.S14756930050322
   PubMed Web of Science ®Google Scholar
• Meng W, Ye Z, Cui R, et al. MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma. Clin Cancer Res. 2013;19(19):5423–5433. doi:10.1158/1078-0432.CCR-13-032023946296
   PubMed Web of Science ®Google Scholar
• Jian J, Xiong F, Xia W, et al. Fully convolutional networks (FCNs)-based segmentation method for colorectal tumors on T2-weighted magnetic resonance images. Australas Phys Eng Sci Med. 2018;41(2):393–401. doi:10.1007/s13246-018-0636-929654521
   PubMed Web of Science ®Google Scholar